Clinical Trials

September 17, 2026

Sponsored by Anagram Therapeutics Anagram Therapeutics, Inc is developing a non-porcine Pancreatic Enzyme Replacement Therapy (PERT)- ANG003. For people with Cystic Fibrosis (PwCF) with exocrine pancreatic insufficiency (EPI), the currently approved PERTs are porcine (pig) derived and require enteric (plastic) coating to allow the capsules to...

A Clinical Study for People with Cystic Fibrosis (CF) Who Have Specific Mutations in the CFTR Gene, Which Are the Cause of CF

by Emma Mueller

Clinical Trials

November 19, 2025

Sponsored by ReCode Therapeutics Despite the availability of CFTR modulators that work for 90% of people with CF, many will not be able to take the medication due to side effects, lack of response, or other reasons. About 10% of the CF community have genetic mutations...

A New Approach to Treating CF-Associated Infections

by Emma Mueller

Clinical Trials

October 2, 2025

Post sponsored by Clarametyx While new therapies for cystic fibrosis (CF) are increasingly available to our community, many people with CF still face persistent and repeated infections that require the use of antibiotics. Now, researchers are developing a new approach to address these chronic infections by...

The Importance of CF Research by Maria Clark

by Emma Mueller

Clinical Trials

May 7, 2025

For patients and their families, the journey with CF is relentless, but thanks to decades of dedicated scientific research, that journey has become one of increasing hope and progress. I have personally participated in various research studies at Children’s Hospital of Philadelphia and University of...

Clinical Trials

A New Pancreatic Enzyme Therapy (ANG003)

A Clinical Study for People with Cystic Fibrosis (CF) Who Have Specific Mutations in the CFTR Gene, Which Are the Cause of CF

A New Approach to Treating CF-Associated Infections

The Importance of CF Research by Maria Clark

Never miss an update. Subscribe to our emails!